Advances in Clinical and Experimental Medicine

Adv Clin Exp Med
Impact Factor (IF) – 1.227
Index Copernicus (ICV 2018) – 157.72, MNiSW – 40
Average rejection rate – 84.38%
ISSN 1899–5276 (print),   ISSN 2451-2680 (online)
Periodicity – monthly

Contents – 2008, Vol. 17, No. 4 (July-August)

1

Editorial Article

Cellular and Intercellular Signaling in Rheumatoid Arthritis – New Therapeutic Targets

379-386

2

Original Article

Side Effects of Methotrexate Treatment in Patients With Rheumatoid Arthritis

387-394

3

Original Article

Serum and Synovial Fluid Nitrite Levels in Patients With Rheumatoid Arthritis and Osteoarthritis

395-398

4

Original Article

Activation of STAT−1, −3, and −6 Proteins in Early Arthritis

399-404

5

Original Article

The Activity of STAT−3 in Patients With Rheumatoid Arthritis

405-409

6

Original Article

Serum Levels of Soluble Fas in Rheumatoid Arthritis Patients Treated With Infliximab

411-414

7

Original Article

iNOS Expression in Peripheral Blood Leukocytes of Patients With Early Arthritis and Established Rheumatoid Arthritis

415-421

8

Review Article

Pharmacotherapy of Rheumatic Diseases in Pregnancy

423-431

9

Review Article

Perspectives of Systemic Lupus Erythematosus Therapy

433-439

10

Review Article

Immunological Aspects of Systemic Sclerosis and New Strategies in Therapy

441-446

11

Review Article

The Role of Jak/STAT Signaling in Rheumatoid Arthritis

447-452

12

Review Article

Optimization of Rheumatoid Diseases Therapy

453-461

13

Review Article

The Role of a Pharmacist in Rheumatoid Diseases Therapy

463-469

14

Review Article

The Influence of Rheumatoid Diseases Pharmacotherapy on Laboratory Findings

471-478

15

Review Article

Jak3 – Its Significance in Inflammatory Diseases of Joints – New Perspectives for Therapy

479-484